Condition
Stage I Lung Cancer AJCC v8
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 34 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
34 shownHotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung CancerNCT07718672 · 2026-09-01
RECRUITINGNew York Better Breathing StudyNCT06869447 · 2026-04-20
RECRUITINGQuality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerNCT05292521 · 2023-12-21
RECRUITINGStereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI StudyNCT05802186 · 2023-11-20
RECRUITINGThe Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung CancerNCT05502523 · 2022-08-31
RECRUITINGCanakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung TrialNCT04789681 · 2021-07-20
RECRUITINGRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · 2021-02-21
RECRUITINGRespiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerNCT04067830 · 2019-03-20
RECRUITINGDyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNCT03948100 · 2018-12-20
RECRUITINGOral Iloprost for the Prevention of Lung Cancer In Former SmokersNCT05411107 · 2024-06-01
WITHDRAWNPilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungNCT05412875 · 2024-01-01
WITHDRAWNRobotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING StudyNCT04987281 · 2022-01-26
WITHDRAWNEffects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung CancerNCT04857697 · 2021-07-01
COMPLETEDRegistrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology TreatmentNCT04862195 · 2021-05-15
TERMINATEDCognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025 · 2021-04-08
TERMINATEDSapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME StudyNCT05022394 · 2021-02-18
WITHDRAWNNBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung CancerNCT04505267 · 2021-02-10
ACTIVE_NOT_RECRUITINGSirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung CancerNCT04348292 · 2021-01-22
TERMINATEDTesting the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung CancerNCT04214262 · 2020-08-13
ACTIVE_NOT_RECRUITINGDecision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung CancerNCT04946279 · 2020-08-07
ACTIVE_NOT_RECRUITINGBintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung CancerNCT04560686 · 2020-08-05
TERMINATEDFamily Caregivers in Underserved Populations Providing Complex Cancer CareNCT05213078 · 2020-07-15
COMPLETEDSelf-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerNCT04428905 · 2020-07-11
ACTIVE_NOT_RECRUITINGPembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerNCT04061590 · 2020-05-29
WITHDRAWNCharacterizing Chemo-Radiotherapy Treatment-Related Cardiac ChangesNCT04183218 · 2019-09-23
COMPLETEDMicrowave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyNCT04430725 · 2019-08-07
ACTIVE_NOT_RECRUITINGTesting the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)NCT03811002 · 2019-07-26
ACTIVE_NOT_RECRUITINGTumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerNCT03995667 · 2019-06-11
TERMINATEDTreatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481 · 2019-05-14
ACTIVE_NOT_RECRUITINGGeriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversNCT03902535 · 2019-03-08
COMPLETEDPatient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNCT03867916 · 2018-12-13
COMPLETEDOnline Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentNCT03731585 · 2018-11-15
ACTIVE_NOT_RECRUITINGPembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung StudyNCT03634241 · 2018-11-13
COMPLETEDStereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerNCT03110978 · 2017-06-26
ACTIVE_NOT_RECRUITINGCommon interventions
Questionnaire AdministrationOTHER17Quality-of-Life AssessmentOTHER13Biospecimen CollectionPROCEDURE9Best PracticeOTHER5Computed TomographyPROCEDURE5Stereotactic Body Radiation TherapyRADIATION4Educational InterventionOTHER3Positron Emission TomographyPROCEDURE3Therapeutic Conventional SurgeryPROCEDURE3AtezolizumabDRUG2CisplatinDRUG2Informational InterventionOTHER2NivolumabBIOLOGICAL2PembrolizumabBIOLOGICAL2Radiation TherapyRADIATION2Survey AdministrationOTHER23-Dimensional Conformal Radiation TherapyRADIATION1Attune™DEVICE1Behavioral InterventionBEHAVIORAL1Bintrafusp AlfaDRUG1BiopsyPROCEDURE1Biospecimen CollectionOTHER1Bronchial Brush BiopsyPROCEDURE1BronchoscopyPROCEDURE1CanakinumabDRUG1
Leading sponsors
M.D. Anderson Cancer Center
11
Roswell Park Cancer Institute
4
City of Hope Medical Center
3
National Cancer Institute (NCI)
3
Mayo Clinic
2
OHSU Knight Cancer Institute
2
University of California, San Francisco
2
Blue Note Therapeutics
1
Emory University
1
Jonsson Comprehensive Cancer Center
1
Northwestern University
1
Ohio State University Comprehensive Cancer Center
1
SWOG Cancer Research Network
1
Thomas Jefferson University
1
Trial status mix
ACTIVE_NOT_RECRUITING9
RECRUITING9
COMPLETED6
TERMINATED5
WITHDRAWN5
Phase mix
NA12
PHASE211
PHASE14
PHASE33
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.